innovent glp 1 Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China's NMPA for Chronic Weight Management GLP-1 Injection: Innovent's GLP-1 Drug
Description
FDA-approved medicines containing Tirzepatide are available
This class of medications treats type 2 diabetes and obesity
While this has not been observed in humans at standard doses, and microdoses are far below standard doses, patients with existing thyroid conditions (including Hashimoto) should have regular thyroid monitoring
These costs are not temporary
10.1038/s41467-021-27760-0 13 Diz-ChavesY.MaastorZ.SpuchC.LamasJ
Rein DB et al
